Global and United States Infectious Disease Clinical Trials Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Infectious Disease Clinical Trials Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Infectious Disease Clinical Trials Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Infectious Disease Clinical Trials Market Size for the Year 2017-2028
  • 1.2.2 Global Infectious Disease Clinical Trials Market Size for the Year 2017-2028
• 1.3 Infectious Disease Clinical Trials Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Infectious Disease Clinical Trials in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Infectious Disease Clinical Trials Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Infectious Disease Clinical Trials Market Dynamics
  • 1.4.1 Infectious Disease Clinical Trials Industry Trends
  • 1.4.2 Infectious Disease Clinical Trials Market Drivers
  • 1.4.3 Infectious Disease Clinical Trials Market Challenges
  • 1.4.4 Infectious Disease Clinical Trials Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Infectious Disease Clinical Trials by Type

• 2.1 Infectious Disease Clinical Trials Market Segment by Type
  • 2.1.1 Phase I
  • 2.1.2 Phase II
  • 2.1.3 Phase III
  • 2.1.4 Phase IV
• 2.2 Global Infectious Disease Clinical Trials Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Infectious Disease Clinical Trials Market Size by Type (2017-2028)
• 2.4 United States Infectious Disease Clinical Trials Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Infectious Disease Clinical Trials Market Size by Type (2017-2028)

3 Infectious Disease Clinical Trials by Application

• 3.1 Infectious Disease Clinical Trials Market Segment by Application
  • 3.1.1 Vaccines
  • 3.1.2 Cell & Gene Therapy
  • 3.1.3 Others
• 3.2 Global Infectious Disease Clinical Trials Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Infectious Disease Clinical Trials Market Size by Application (2017-2028)
• 3.4 United States Infectious Disease Clinical Trials Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Infectious Disease Clinical Trials Market Size by Application (2017-2028)

4 Global Infectious Disease Clinical Trials Competitor Landscape by Company

• 4.1 Global Infectious Disease Clinical Trials Market Size by Company
  • 4.1.1 Top Global Infectious Disease Clinical Trials Companies Ranked by Revenue (2021)
  • 4.1.2 Global Infectious Disease Clinical Trials Revenue by Player (2017-2022)
• 4.2 Global Infectious Disease Clinical Trials Concentration Ratio (CR)
  • 4.2.1 Infectious Disease Clinical Trials Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Infectious Disease Clinical Trials in 2021
  • 4.2.3 Global Infectious Disease Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Infectious Disease Clinical Trials Headquarters, Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Infectious Disease Clinical Trials Headquarters and Area Served
  • 4.3.2 Global Infectious Disease Clinical Trials Companies Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Infectious Disease Clinical Trials Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Infectious Disease Clinical Trials Market Size by Company
  • 4.5.1 Top Infectious Disease Clinical Trials Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Infectious Disease Clinical Trials Revenue by Players (2020, 2021 & 2022)

5 Global Infectious Disease Clinical Trials Market Size by Region

• 5.1 Global Infectious Disease Clinical Trials Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Infectious Disease Clinical Trials Market Size by Region (2017-2028)
  • 5.2.1 Global Infectious Disease Clinical Trials Market Size by Region: 2017-2022
  • 5.2.2 Global Infectious Disease Clinical Trials Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
  • 6.1.2 North America Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Infectious Disease Clinical Trials Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
  • 6.4.6 Colombia
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 IQVIA
  • 7.1.1 IQVIA Company Details
  • 7.1.2 IQVIA Business Overview
  • 7.1.3 IQVIA Infectious Disease Clinical Trials Introduction
  • 7.1.4 IQVIA Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.1.5 IQVIA Recent Development
• 7.2 LabCorp
  • 7.2.1 LabCorp Company Details
  • 7.2.2 LabCorp Business Overview
  • 7.2.3 LabCorp Infectious Disease Clinical Trials Introduction
  • 7.2.4 LabCorp Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.2.5 LabCorp Recent Development
• 7.3 Charles River
  • 7.3.1 Charles River Company Details
  • 7.3.2 Charles River Business Overview
  • 7.3.3 Charles River Infectious Disease Clinical Trials Introduction
  • 7.3.4 Charles River Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.3.5 Charles River Recent Development
• 7.4 WuXi AppTec
  • 7.4.1 WuXi AppTec Company Details
  • 7.4.2 WuXi AppTec Business Overview
  • 7.4.3 WuXi AppTec Infectious Disease Clinical Trials Introduction
  • 7.4.4 WuXi AppTec Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.4.5 WuXi AppTec Recent Development
• 7.5 Syneos Health
  • 7.5.1 Syneos Health Company Details
  • 7.5.2 Syneos Health Business Overview
  • 7.5.3 Syneos Health Infectious Disease Clinical Trials Introduction
  • 7.5.4 Syneos Health Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.5.5 Syneos Health Recent Development
• 7.6 PPD
  • 7.6.1 PPD Company Details
  • 7.6.2 PPD Business Overview
  • 7.6.3 PPD Infectious Disease Clinical Trials Introduction
  • 7.6.4 PPD Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.6.5 PPD Recent Development
• 7.7 ICON Plc
  • 7.7.1 ICON Plc Company Details
  • 7.7.2 ICON Plc Business Overview
  • 7.7.3 ICON Plc Infectious Disease Clinical Trials Introduction
  • 7.7.4 ICON Plc Revenue in Infectious Disease Clinical Trials Business (2017-2022)
  • 7.7.5 ICON Plc Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details